The patient from whom this mutation was identified developed aggressive metastatic disease, therefore we postulated that RAD51 G151D may have contributed to the acquisition of the invasive and eventual metastatic behavior of the tumor cells. The gene discussed is RAD51; the disease is metastatic neoplasm.